EVALUATION OF THE NOCEBO EFFECT WHEN SWITCHING FROM THE ORIGINATOR MOLECULE TO A BIOSIMILAR IN A NORMANDY RETROSPECTIVE COHORT OF PATIENTS WITH INFLAMMATORY RHEUMATISM TREATED WITH ETANERCEPT OR ADALIMUMAB (BIONORIC STUDY)

被引:0
作者
Hagege, O. [1 ]
Lequerre, T. [1 ]
Marcelli, C. [2 ]
Varin, R. [3 ]
Alcaix, D. [4 ]
Weber, A. J. [5 ]
Mihailescu, S. D. [6 ]
Duhamel, E. [3 ]
Vittecoq, O. [1 ]
机构
[1] Rheumatol, Rouen, France
[2] Rheumatol, Caen, France
[3] CHU Charles Nicolle, Clin Pharmacol, Rouen, France
[4] Grp Hosp Havre, Rheumatol, Montivilliers, France
[5] Rheumatol, Evreux, France
[6] Publ Hlth, Evreux, France
关键词
Spondyloarthritis; Rheumatoid arthritis; bDMARD;
D O I
10.1136/annrheumdis-2023-eular.4416
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB1615
引用
收藏
页码:2042 / 2042
页数:1
相关论文
共 2 条
[1]   Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study [J].
Cohen, Stanley ;
Genovese, Mark C. ;
Choy, Ernest ;
Perez-Ruiz, Fernando ;
Matsumoto, Alan ;
Pavelka, Karel ;
Pablos, Jose L. ;
Rizzo, Warren ;
Hrycaj, Pawel ;
Zhang, Nan ;
Shergy, William ;
Kaur, Primal .
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (10) :1679-1687
[2]   To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry [J].
Glintborg, Bente ;
Loft, Anne Gitte ;
Omerovic, Emina ;
Hendricks, Oliver ;
Linauskas, Asta ;
Espesen, Jakob ;
Danebod, Kamilla ;
Jensen, Dorte Vendelbo ;
Nordin, Henrik ;
Dalgaard, Emil Barner ;
Chrysidis, Stavros ;
Kristensen, Salome ;
Raun, Johnny Lillelund ;
Lindegaard, Hanne ;
Manilo, Natalia ;
Jakobsen, Susanne Hojmark ;
Hansen, Inger Marie Jensen ;
Pedersen, Dorte Dalsgaard ;
Sorensen, Inge Juul ;
Andersen, Lis Smedegaard ;
Grydehoj, Jolanta ;
Mehnert, Frank ;
Krogh, Niels Steen ;
Hetland, Merete Lund .
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (02) :192-200